New source of lymphatic system leak discovered in children with rare open heart surgery complication

November 11, 2020

WILMINGTON, Del. (November 11, 2020) - Interventional radiologists with Nemours Children's Health System have identified a new source of abnormal lymphatic flow between the liver and the lungs that may be responsible for some cases of plastic bronchitis. Plastic bronchitis is a rare but serious late complication in patients with congenital heart disease who had Fontan surgery. A report detailing the discovery of this fluid leak, and successful treatment of two cases was published in European Heart Journal.

In plastic bronchitis, lymph fluid drains into the lungs, blocking patients' airways and causing difficulty breathing. Recent advances in the use of dynamic contrast-enhanced magnetic resonance lymphangiogram have identified that in 94% of patients, the cause is identified as lymph fluid draining from the thoracic duct that can be successfully treated by blocking or embolizing this duct. However, in a subset of patients, the leak cannot be identified and treated.

"Through sophisticated lymphatic imaging techniques, we have identified a new source of lymph fluid leak from the liver to the chest in patients with plastic bronchitis, opening up treatment options where there previously were none," said Deborah A. Rabinowitz, MD, an interventional radiologist with Nemours Children's Health System in Wilmington, Del. "This discovery signals a connection between the liver's lymph system and chest structures that could explain pulmonary symptoms in patients with other conditions, such as congestive heart failure and liver cirrhosis."

The case report details the care of two teen boys who had previously undergone Fontan surgery, an open heart surgery which directs blood flow to the lungs. The first patient was transferred to Nemours/Alfred I. duPont Hospital for Children after unsuccessful identification of lymph fluid leak. Further lymphatic imaging identified the leaking duct from the liver. Despite the complexity of the liver's lymphatic anatomy, the abnormal pathway was identified and embolized to treat this patient's condition.

The second patient was transferred to Nemours for emergent care for a persistent cough and fatigue. Once diagnosed with plastic bronchitis, the team did not identify the more common leaks in the thoracic ducts. But based on the experience with the first patient, the second patient underwent liver lymphangiogram, which identified a similar leak from the liver to the airway. This discovery enabled the team to embolize the leaking duct with immediate relief of his symptoms.

This discovery improves our understanding of the role of the liver as a source of plastic bronchitis in select patients, and advances an innovative and effective treatment approach.
About Nemours Children's Health System. Nemours is an internationally recognized children's health system that owns and operates the Nemours/Alfred I. duPont Hospital for Children in Wilmington, Del., and Nemours Children's Hospital in Orlando, Fla., along with outpatient facilities in five states, delivering pediatric primary, specialty, and urgent care. Nemours also powers the world's most-visited website for information on the health of children and teens, and offers on-demand, online video patient visits through Nemours CareConnect.

Established as The Nemours Foundation through the legacy and philanthropy of Alfred I. duPont, Nemours provides pediatric clinical care, research, education, advocacy, and prevention programs to families in the communities it serves.


Related Congenital Heart Disease Articles from Brightsurf:

Low risk of COVID-19 infection found among people with congenital heart disease
Results of a retrospective analysis suggest that people born with a heart defect who developed COVID-19 symptoms had a low risk of moderate or severe COVID-19 infection, according to a new article published today in the Journal of the American Heart Association, an open access journal of the American Heart Association.

New method for in utero 4D imaging of baby hearts may aid diagnosis of congenital heart disease
Researchers at King's College London have developed a new method for helping detect congenital heart disease of a baby in pregnant mothers using MRI.

Gout treatment may aid patients with congenital heart disease
A drug used to treat gout, probenecid, may improve heart function in individuals with a particular heart defect, according to results from a small pilot study run by a University of Cincinnati researcher.

Stakeholders update newborn screening guidelines for critical congenital heart disease
A distinguished panel of medical experts, state and federal health officials, and congenital heart disease parent advocates published recommended updates to the current American Academy of Pediatrics' protocol for detecting critical congenital heart disease (CCHD) in newborn babies using pulse oximetry.

Congenital heart disease more deadly in low-income countries
Even though mortality from congenital heart disease (CHD) has declined over the last three decades as diagnosis and treatments have advanced, a new study shows that the chances for a child to survive a CHD diagnosis significantly differs based on the country where he or she is born.

Telehealth effectively diagnoses/manages fetal congenital heart disease in rural patients
A recent study of 368 pregnant mothers, led by Bettina Cuneo, MD, director of perinatal cardiology and fetal cardiac telemedicine at Children's Hospital Colorado, found that fetal congenital heart disease (CHD) was correctly identified and successfully managed according to evidence-based risk stratification.

Uncorrected congenital heart disease may lead to increased risks in pregnant women
Pregnant women with congenital heart disease (CHD) who have not had surgery to repair their cardiac condition are more likely to experience cardiac events or maternal death, especially those with certain conditions in emerging countries, according to a study published Oct.

A new framework to study congenital heart defects
In a new study published in the scientific journal Nature, a team of researchers at the Gladstone Institutes, in collaboration with the University of Luxembourg, reveal for the first time the full spectrum of cells that come together to make a heart at the earliest stages of embryo formation.

Risk of cancer among children, young adults with congenital heart disease
National registry data in Sweden were used in this study that assessed the risk of developing cancer in children and young adults with congenital heart disease compared with healthy people in the general population from birth to age 41.

Congenital heart defects vastly increase risk of heart problems later in life
An infant born with a relatively simple heart defect is far more likely to develop heart problems as an adult, researchers at the Stanford University School of Medicine have discovered.

Read More: Congenital Heart Disease News and Congenital Heart Disease Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to